Ashwin Balakrishnan

UCSF Urology Resident

[Manoj Monga @endourologyucsd]

Low hanging fruit (and vegetables): addressing food insecurity in disadvantaged communities - Dr Bayne ⁦@ROCKUrology⁩ #aua24

[Lindsay Hampson @lindsayahampson]

@UCSFUrology resident @_ashwin_bala with a great presentation on how socioeconomic status and healthy food might impact 24 hour urine parameters. 🪨🪨🪨

@thomaschi8 @DBBayneMD @HeikoYangMDPhD

[Anteneh @antyeneh]

I attended a week long simulation based and hands on training on ultrasound guided PCNL and URS by @UCSFUrology . A lot of knowledge amd skill unpacked and a potential collaboration and partnership was made.Delighted about it. Can't wait to expand it to 🇪🇹 and 🇰🇪@UCSF_CHESA

[UCSFUrology @UCSFUrology]

The collaboration between UCSF Urology and Mulago Hospital in Kampala, Uganda continues to grow!
@UCSFUrology @UCSF_CHESA @DBBayneMD @_ashwin_bala @taata_imran @RubabindaJr @Job_Kuteesa_MD @antyeneh

[UCSFUrology @UCSFUrology]

Using low cost models they designed, @DBBayneMD and @_ashwin_bala lead simulation workshops with East African urologists to teach skills in flexible ureteroscopy and ultrasound guided PCNL. The models will be used locally for ongoing training.

[Journal of Urology @JUrology]

Active surveillance for #prostatecancer
Data from @_ashwin_bala @dr_coops
@pcarroll_ @UCSFUrology
No difference in recurrence rates
after RP if GG1 or low-volume GG2
High-volume GG2 (2 or more cores)
more likely to recur
https://t.co/J3YIGCwWlo
#pcsm

[Ashwin Balakrishnan @_ashwin_bala]

With a text-message reminder and education program for prostate biopsy patients, we reduced overall canceled or rescheduled appointments by 37% (33.8% vs 21.2%, P<.001) and same-day cancellations by 87% (3.8% vs 0.5%, P<.001). @anobelodisho @pcarroll_ @haognguyen

[JMIR Publications @jmirpub]

New in JMIR: A Mobile #Health Intervention for Prostate Biopsy ##Patients Reduces Appointment Cancellations: Cohort #Study https://t.co/XfALGcciQ4

[Ashwin Balakrishnan @_ashwin_bala]

Our results support safety of AS for patients with GG1 and select patients with GG2 at dx. Men with GG2 and 2+ high grade cores at dx may benefit from earlier curative treatment. #AUA19 @pcarroll_ @dr_coops @UCSFUrology

[Prof. Prokar Dasgupta OBE HonFREng @prokarurol]

#AUA19 ⁦@anobelodisho⁩ on reducing cancelled patient appointments by text messaging

[Ashwin Balakrishnan @_ashwin_bala]

Thanks @urotoday for sharing our work, which shows low treatment-guideline compliance for patients with cT1 bladder cancer. However, there is a trend toward increased use of guideline-based treatment (BCG or upfront RC). @SimaPorten @samwashuro @Uro_Max

[UroToday.com @urotoday]

GO #BeyondTheAbstract w/ @SimaPorten @_ashwin_bala Samuel Washington & @Uro_Max : Determinants of Guideline-Based Treatment in Patients w/ cT1 #BladderCancer @UCSFCancer
https://t.co/6VDmZrAb5U

[UCSFUrology @UCSFUrology]

@ben_breyer in @JUrology on, "Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement" https://t.co/QYzaruuzl6